Obesity 30 , 129141 (2022)
Originally developed for managing type 2 diabetes, semaglutide GLP-1 has shown exceptional results in reducing body weight, leading to its approval for this purpose
A, A mechanistic study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) secretion from enteroendocrine L cells
"If we can kind of, like, tease out what is the effect of weight loss versus what is the direct effect of these medications on the upper airway, that will be very interesting." The most common side effects of GLP-1 drugs, including tirzepatide, are nausea, vomiting, diarrhea and constipation
Brain Fog and Poor Focus Blood sugar instability can affect the brain too
Administering a beta-blocker in this state eliminates vital compensatory cardiac mechanisms (such as increased contractility), leaving the -1-stimulation unopposed (Medical Advisory Board 2026b)